Surgical adrenalectomy with diurnal corticosterone replacement slows escalation and prevents the augmentation of cocaine-induced reinstatement in rats self-administering cocaine under long-access conditions

Neuropsychopharmacology

Volumn 33, Issue 4, 2008, Pages 814-826

  Mantsch, John R ^a   Baker, David A ^a   Serge, Joseph P ^a   Hoks, Michael A ^a   Francis, David M ^a   Katz, Eric S ^a  

^a MARQUETTE UNIVERSITY   (United States)

Author keywords

Addiction; Cocaine; Corticosterone; Escalation; Neuroplasticity; Relapse

Indexed keywords

COCAINE; CORTICOSTERONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; COCAINE DEPENDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; DRUG SELF ADMINISTRATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ADRENALECTOMY; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; HORMONE REPLACEMENT THERAPY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); TIME FACTORS;

EID: 39149108447     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301464     Document Type: Article

References (49)

1. Ahima RS, Harlan RE (1990). Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39: 579-604.
2. Ahmed SH, Cador M (2006). Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology 31: 563-571.
3. Ahmed SH, Koob GF (1999). Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology 146: 303-312.
4. Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300.
5. Ahmed SH, Koob GF (2004). Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake. Psychopharmacology 172: 450-454.
6. Ahmed SH, Lin D, Koob GF, Parsons LH (2003). Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J Neurochem 86: 102-113.
7. Baker DA, Tran-Nguyen LT, Fuchs RA, Neisewander JL (2001). Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats. Psychopharmacology 155: 18-26.
8. Barrot M, Marinelli M, Abrous DN, Rouge-Pont F, Le Moal M, Piazza PV (2000). The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12: 973-979.
9. Ben-Shahar O, Moscarello JM, Ettenberg A (2006). One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter. Brain Res 1095: 148-153.
10. Borrell J, de Kloet ER, Verteeg DH, Bohus B (1983). Inhibitory avoidance deficit following short-term adrenalectomy in the rat: the role of adrenal catecholamines. Behav Neural Biol 39: 241-258.
11. Broadbear JH, Winger G, Woods JH (1999). Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary- adrenal response. J Pharmacol Exp Ther 290: 1347-1355.
12. Campbell UC, Carroll ME (2001). Effects of ketoconazole on the acquisition of intravenous cocaine self-administration under different feeding conditions in rats. Psychopharmacology 154: 311-318.
13. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78: 4704-4707.
14. de Kloet ER, Joels M, Holsboer F (2005). Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463-475.
15. Deroche V, Marinelli M, Le Moal M, Piazza PV (1997). Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281: 1401-1407.
16. Doron R, Fridman L, Gispan-Herman I, Maayan R, Weizman A, Yadid G (2006). DHEA, a neurosteroid, decreases cocaine self-administration and reinstatement of cocaine-seeking behavior in rat. Neuropsychopharmacology 31: 2231-2236.
17. Erb S, Shaham Y, Stewart J (1998). The role of corticotrophin-releasing factor and corticosterone in stress- and cocaineinduced relapse to cocaine seeking in rats. J Neurosci 18: 5529-5536.
18. Ferrario CR, Gorny G, Crombag HS, Li Y, Kolb B, Robinson TE (2005). Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58: 751-759.
19. Galici R, Pechnick RN, Poland RE, France CP (2000). Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats. Eur J Pharmacol 387: 59-62.
20. Ghitza UE, Rothman RB, Gorelick DA, Henningfield JE, Baumann MH (2007). Serotonergic responsiveness in human cocaine users. Drug Alcohol Depend 86: 207-213.
21. Goeders NE, Guerin GF (1996a). Role of corticosterone in intravenous cocaine self-administration. Neuroendocrinology 64: 337-348.
22. Goeders NE, Guerin GF (1996b). Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 25: 145-152.
23. Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstrom AC et al (1986). Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci USA 83: 9779-9783.
24. Jacobson L, Akana SF, Cascio CS, Shinsako J, Dallman MF (1988). Circadian variations in plasma corticosterone permit normal termination of the adrenocorticotropin responses to stress. Endocrinology 122: 1343-1348.
25. Joels M, de Kloet ER (1994). Mineralocorticoid and glucocorticoid receptors in the brain: implications for ion permeability and transmitter systems. Prog Neurobiol 43: 1-36.
26. Kippin TE, Fuchs RA, See RE (2006). Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats. Psychopharmacology 187: 60-67.
27. Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A (2002). Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend 66: 173-180.
28. Lee B, Tiefenbacher S, Platt DM, Spealman RD (2003). Role of the hypothalamic-pituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys. Psychopharmacology 168: 177-183.
29. Mantsch JR, Goeders NE (1999). Ketoconazole does not block cocaine discrimination or the cocaine-induced reinstatement of cocaine-seeking behavior. Pharmacol Biochem Behav 64: 65-73.
30. Mantsch JR, Katz ES (2007). Elevation of glucocorticoids is necessary but not sufficient for the escalation of cocaine selfadministration by chronic electric footshock stress in rats. Neuropsychopharmacology 32: 367-376.
31. Mantsch JR, Saphier D, Goeders NE (1998). Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II receptor agonist dexamethasone. J Pharmacol Exp Ther 287: 72-80.
32. Mantsch JR, Yuferov V, Mathieu-Kia A-M, Ho A, Kreek MJ (2003). Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology 28: 836-862.
33. Mantsch JR, Yuferov V, Mathieu-Kia A-M, Ho A, Kreek MJ (2004). Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 175: 26-36.
34. Marinelli M, Piazza PV, Deroche V, Maccari S, Le Moal M, Simon H (1994). Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J Neurosci 14: 2724-2731.
35. Mateo Y, Lack CM, Morgan D, Roberts DC, Jones SR (2005). Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30: 1455-1463.
36. McCracken CB, Hamby SM, Patel KM, Morgan D, Vrana KE, Roberts DC (2005). Extended cocaine self-administration and deprivation produces region-specific and time-dependent changes in connexin36 expression in rat brain. Synapse 58: 141-150.
37. McEwen BS (2005). Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54: 20-23.
38. Meyer JS, Micco DJ, Stephenson BS, Krey LC, McEwen BS (1979). Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol Behav 22: 867-870.
39. Peskind ER, Raskind MA, Wilkinson CW, Flatness DE, Halter JB (1986). Peripheral sympathectomy and adrenal medullectomy do not alter cerebrospinal fluid norepinephrine. Brain Res 367: 258-264.
40. Piazza PV, Rouge-Pont F, Deroche V, Maccari S, Simon H, Le Moal M (1996). Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic neurotransmission. Proc Natl Acad Sci USA 93: 8716-8720.
41. Prasad BM, Ulibarri C, Sorg BA (1998). Stress-induced crosssensitization to cocaine: effect of adrenalectomy and corticosterone after short- and long-term withdrawal. Psychopharmacology 136: 24-33.
42. Rouge-Pont F, Marinelli M, Le Moal M, Simon H, Piazza PV (1995). Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J Neurosci 15: 7189-7195.
43. Saal D, Dong Y, Bonci A, Malenka RC (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577-582.
44. Sapolsky RM, Romero M, Munck AU (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Rev 21: 55-89.
45. Sutton MA, Karanian DA, Self DW (2000). Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats. Neuropsychopharmacology 22: 626-641.
46. Van Craenenbroeck K, De Bosscher K, Vanden Berghe W, Vanhoenacker P, Haegeman G (2005). Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol Cell Endocrinol 245: 10-22.
47. Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW (1999). Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans. Behav Pharmacol 10: 523-529.
48. Weinshenker D, Schroeder JP (2006). There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology [E-pub ahead of print; doi:10.1038/sj.npp.1301263].
49. Yang YL, Chao PK, Lu KT (2006). Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 31: 912-924.